‘A slow and painful journey’: why did it take over 20 years to approve the new Alzheimer’s drug?

Authors/Creators

Ralph N. Martins, Edith Cowan UniversityFollow

Document Type

Article

Date of Publication

2-18-2021

School

School of Medical and Health Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.

Copyright

free_to_read

Publisher

The Conversation Media Group Ltd

Comments

Martins, R. (2021). ‘A slow and painful journey’: why did it take over 20 years to approve the new Alzheimer’s drug? The Conversation. https://theconversation.com/a-slow-and-painful-journey-why-did-it-take-over-20-years-to-approve-the-new-alzheimers-drug-162603

Recommended Citation

Martins, R. N. (2021). ‘A slow and painful journey’: why did it take over 20 years to approve the new Alzheimer’s drug?. Retrieved from https://ro.ecu.edu.au/ecuworkspost2013/10969